Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1987 Oct;80(4):1125–1131. doi: 10.1172/JCI113169

Demonstration of 2-hydroxybenzoylglycine as a drug binding inhibitor in newborn infants.

B Suh 1, S J Wadsworth 1, D M Lichtenwalner 1
PMCID: PMC442355  PMID: 3654972

Abstract

Newborn infants have drug binding defects that share similarities to those of uremic subjects. Since 2-hydroxybenzoylglycine has been chemically defined to be a major drug binding inhibitor in uremia, a search for the presence of a similar compound in the sera of newborn infants was made. An organic substance that has the characteristics of 2-hydroxybenzoylglycine as supported by the retardation factor values on thin-layer chromatograms, retention times of high performance liquid chromatograms, fluorescence emission spectra, and mass spectrum has been demonstrated to be present in the majority of the neonatal sera studied. A strong positive correlation between the levels of the binding inhibitor and the extent of binding defects for nafcillin has been observed. The substance could effectively reduce the total bilirubin concentration when added to the cord sera specimens. It is concluded that 2-hydroxybenzoylglycine plays an important role in drug binding defects observed in the newborn, and the inhibitor may also play a part in the precipitation of bilirubin-induced neurotoxicity in neonates when the substance is abnormally elevated.

Full text

PDF
1125

Images in this article

1126Image
on p.1126

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOOTH A. N., ROBBINS D. J., DUNKLEY W. L. Occurrence of salicyluric acid in milk. Nature. 1962 Apr 21;194:290–291. doi: 10.1038/194290a0. [DOI] [PubMed] [Google Scholar]
  2. Chignell C. F., Vesell E. S., Starkweather D. K., Berlin C. M. The binding of sulfaphenazole to fetal, neonatal, and adult human plasma albumin. Clin Pharmacol Ther. 1971 Nov-Dec;12(6):897–901. doi: 10.1002/cpt1971126897. [DOI] [PubMed] [Google Scholar]
  3. Craig W. A., Evenson M. A., Sarver K. P., Wagnild J. P. Correction of protein binding defect in uremic sera by charcoal treatment. J Lab Clin Med. 1976 Apr;87(4):637–647. [PubMed] [Google Scholar]
  4. Doumas B. T., Watson W. A., Biggs H. G. Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta. 1971 Jan;31(1):87–96. doi: 10.1016/0009-8981(71)90365-2. [DOI] [PubMed] [Google Scholar]
  5. Feingold B. F. Recognition of food additives as a cause of symptoms of allergy. Ann Allergy. 1968 Jun;26(6):309–313. [PubMed] [Google Scholar]
  6. Krasner J., Giacoia G. P., Yaffe S. J. Drug-protein binding in the newborn infant. Ann N Y Acad Sci. 1973 Nov 26;226:101–114. doi: 10.1111/j.1749-6632.1973.tb20473.x. [DOI] [PubMed] [Google Scholar]
  7. Kunin C. M. Clinical pharmacology of the new penicillins. 1. The importance of serum protein binding in determining antimicrobial activity and concentration in serum. Clin Pharmacol Ther. 1966 Mar-Apr;7(2):166–179. doi: 10.1002/cpt196672166. [DOI] [PubMed] [Google Scholar]
  8. Kurz H., Mauser-Ganshorn A., Stickel H. H. Differences in the binding of drugs to plasma proteins from newborn and adult man. I. Eur J Clin Pharmacol. 1977 Jul 19;11(6):463–467. doi: 10.1007/BF00562940. [DOI] [PubMed] [Google Scholar]
  9. Laurell S., Tibbling G. Colorimetric micro-determination of free fatty acids in plasma. Clin Chim Acta. 1967 Apr;16(1):57–62. doi: 10.1016/0009-8981(67)90269-0. [DOI] [PubMed] [Google Scholar]
  10. Lichtenwalner D. M., Suh B., Lichtenwalner M. R. Isolation and chemical characterization of 2-hydroxybenzoylglycine as a drug binding inhibitor in uremia. J Clin Invest. 1983 May;71(5):1289–1296. doi: 10.1172/JCI110879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lichtenwalner D. M., Suh B., Lorber B., Rudnick M. R., Craig W. A. Partial purification and characterization of the drug-binding-defect inducer in uremia. J Lab Clin Med. 1981 Jan;97(1):72–81. [PubMed] [Google Scholar]
  12. Lichtenwalner D. M., Suh B., Lorber B., Sugar A. M. New rapid assay for nafcillin in serum by spectrofluorometry. Antimicrob Agents Chemother. 1979 Aug;16(2):210–213. doi: 10.1128/aac.16.2.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Miyoshi K., Saijo K., Kotani Y., Kashiwagi T., Kawai H. Characteristic properties of fetal human albumin (Alb F) in isomerization equilibrium. Tokushima J Exp Med. 1966 Nov;13(3-4):121–128. [PubMed] [Google Scholar]
  14. Odell G. B. Influence of binding on the toxicity of bilirubin. Ann N Y Acad Sci. 1973 Nov 26;226:225–237. doi: 10.1111/j.1749-6632.1973.tb20484.x. [DOI] [PubMed] [Google Scholar]
  15. Rane A., Lunde P. K., Jalling B., Yaffe S. J., Sjöqvist F. Plasma protein binding of diphenylhydantoin in normal and hyperbilirubinemic infants. J Pediatr. 1971 May;78(5):877–882. doi: 10.1016/s0022-3476(71)80369-4. [DOI] [PubMed] [Google Scholar]
  16. Reidenberg M. M., Affrime M. Influence of disease on binding of drugs to plasma proteins. Ann N Y Acad Sci. 1973 Nov 26;226:115–126. doi: 10.1111/j.1749-6632.1973.tb20474.x. [DOI] [PubMed] [Google Scholar]
  17. Reidenberg M. M., Odar-Cederlöf I., von Bahr C., Borgå O., Sjöqvist F. Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function. N Engl J Med. 1971 Jul 29;285(5):264–267. doi: 10.1056/NEJM197107292850506. [DOI] [PubMed] [Google Scholar]
  18. Roth M. Dosage fluorimétrique de la bilirubine. Clin Chim Acta. 1967 Sep;17(3):487–492. doi: 10.1016/0009-8981(67)90225-2. [DOI] [PubMed] [Google Scholar]
  19. Singhvi S. M., Heald A. F., Gadebusch H. H., Resnick M. E., Difazio L. T., Leitz M. A. Human serum protein binding of cephalosporin antibiotics in vitro. J Lab Clin Med. 1977 Feb;89(2):414–420. [PubMed] [Google Scholar]
  20. Spector A. A., Santos E. C., Ashbrook J. D., Fletcher J. E. Influence of free fatty acid concentration on drug binding to plasma albumin. Ann N Y Acad Sci. 1973 Nov 26;226:247–258. doi: 10.1111/j.1749-6632.1973.tb20486.x. [DOI] [PubMed] [Google Scholar]
  21. Speer F. Allergy to methyl salicylate. Ann Allergy. 1979 Jul;43(1):36–37. [PubMed] [Google Scholar]
  22. Suh B., Lee H. W., Hong S. Y., Kim S., Eshraghi J., Paik W. K. A new HPLC analytical method for o-hydroxyhippuric acid in uremic serum. J Biochem Biophys Methods. 1986 Nov;13(4-5):211–220. doi: 10.1016/0165-022x(86)90100-4. [DOI] [PubMed] [Google Scholar]
  23. Wallace S. Altered plasma albumin in the newborn infant. Br J Clin Pharmacol. 1977 Feb;4(1):82–85. doi: 10.1111/j.1365-2125.1977.tb00673.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES